High sensitivity of the Hematoflow™ solution for chronic myelomonocytic leukemia screening - Université de Rennes Access content directly
Journal Articles Cytometry Part B: Clinical Cytometry Year : 2018

High sensitivity of the Hematoflow™ solution for chronic myelomonocytic leukemia screening

Abstract

Background: Accumulation of classical monocytes CD14++CD16– (also called MO1) ≥ 94% can accurately distinguish chronic myelomonocytic leukemia (CMML) from reactive monocytosis. The HematoFlow™ solution, able to quantify CD16 negative monocytes, could be a useful tool to manage monocytosis which remains a common issue in routine laboratories.Methods: Classical monocytes were quantified from 153 whole blood samples collected on EDTA using both flow cytometry methods, either MO1 percentage determination by the multiparameter assay previously published and regarded here as the reference method, or CD16 negative monocyte percentage determination by the means of HematoFlow™.Results: Both methods of classical monocyte percentage determination were highly and significantly correlated (r = 0.87, P < 0.0001). The HematoFlow™ solution leant toward an overestimation of the genuine classical monocyte percentages obtained by the reference method. Percentages of CD16 negative monocytes provided by HematoFlow were higher than 94% for all the 73 patients displaying classical monocytes MO1 found ≥94% by the reference method, indicating a sensitivity of 100%. Furthermore, the calculation of CD16 negative monocyte percentage can be easily computerized and integrated to the middleware.Conclusions: We propose a new application of the Hematoflow™ solution that can be used as a flag system for monocytosis management and CMML detection.
Fichier principal
Vignette du fichier
Vazquez et al. - High sensitivity of the Hematoflow™ solution for c.pdf (713.65 Ko) Télécharger le fichier
Origin : Files produced by the author(s)
Loading...

Dates and versions

hal-01812481 , version 1 (26-06-2018)

Identifiers

Cite

Romain Vazquez, Mikaël Roussel, Bouchra Badaoui, Nicolas Freynet, Sihem Tarfi, et al.. High sensitivity of the Hematoflow™ solution for chronic myelomonocytic leukemia screening. Cytometry Part B: Clinical Cytometry, 2018, 94 (5), pp.658-661. ⟨10.1002/cyto.b.21600⟩. ⟨hal-01812481⟩
341 View
220 Download

Altmetric

Share

Gmail Facebook X LinkedIn More